(Q41630231)

5 October 2017

Induction of lymphokine-activated killer cells of equine origin: specificity for equine target cells (English)

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

14 October 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

14 October 2022

author name string

C. E. Hormanski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1604800

14 October 2022

R. Truax

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1604800

14 October 2022

S. S. Pourciau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1604800

14 October 2022

R. W. Folsom

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1604800

14 October 2022

D. W. Horohov

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1604800

14 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1604800

14 October 2022

publication date

1 April 1992

1 reference

full work available at URL

5 October 2017

https://api.elsevier.com/content/article/PII:016524279290066Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

https://api.elsevier.com/content/article/PII:016524279290066Y?httpAccept=text/plain

14 October 2022

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

Veterinary Immunology and Immunopathology

14 October 2022

published in

1 reference

5 October 2017

32

1 reference

5 October 2017

1-2

1 reference

5 October 2017

25-36

1 reference

describes a project that uses

5 October 2017

EqT8888

0 references

cites work

Role of CD18 in lymphokine activated killer (LAK) cell-mediated lysis of human monocytes: comparison with other LAK targets

1

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

The use of discontinuous Percoll gradients to separate populations of cells from human bone marrow and peripheral blood

14 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

In vitro growth of cytotoxic human lymphocytes. V. Generation of allospecific cytotoxic lymphocytes to nonimmunogenic antigen by supplementation of in vitro sensitization with partially purified T-cell growth factor

14 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

14 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

Natural cytotoxicity in the dog: description of two new allogeneic tumour targets

14 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

Tumoricidal effect of interleukin-2-activated killer cells in canines

14 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

Bovine natural cell mediated cytotoxicity (NCMC): activation by cytokines.

14 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

14 October 2022

The leukocyte integrins

8

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

28 Separation of lymphoid cells on nylon wool columns

14 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

Large granular lymphocytes from SCID horses develop potent cytotoxic activity after treatment with human recombinant interleukin 2

14 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

14 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

Lymphokine-activated killer cells. Analysis of progenitors and effectors

14 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes

14 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities

14 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

Induction of IL-2 and lymphokine activated killer cells in the cat

14 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

T lymphocyte development in horses. I. Characterization of monoclonal antibodies identifying three stages of T lymphocyte differentiation

14 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0165-2427(92)90066-Y

14 October 2022

Identifiers

1 reference

5 October 2017

1 reference